Unknown

Dataset Information

0

An integrative genomic analysis revealed the relevance of microRNA and gene expression for drug-resistance in human breast cancer cells.


ABSTRACT:

Background

Acquisition of drug-resistance in cancer has led to treatment failure, however, their mechanisms have not been clarified yet. Recent observations indicated that aberrant expressed microRNA (miRNA) caused by chromosomal alterations play a critical role in the initiation and progression of cancer. Here, we performed an integrated genomic analysis combined with array-based comparative hybridization, miRNA, and gene expression microarray to elucidate the mechanism of drug-resistance.

Results

Through genomic approaches in MCF7-ADR; a drug-resistant breast cancer cell line, our results reflect the unique features of drug-resistance, including MDR1 overexpression via genomic amplification and miRNA-mediated TP53INP1 down-regulation. Using a gain of function study with 12 miRNAs whose expressions were down-regulated and genome regions were deleted, we show that miR-505 is a novel tumor suppressive miRNA and inhibits cell proliferation by inducing apoptosis. We also find that Akt3, correlate inversely with miR-505, modulates drug sensitivity in MCF7-ADR.

Conclusion

These findings indicate that various genes and miRNAs orchestrate to temper the drug-resistance in cancer cells, and thus acquisition of drug-resistance is intricately controlled by genomic status, gene and miRNA expression changes.

SUBMITTER: Yamamoto Y 

PROVIDER: S-EPMC3247093 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC4991404 | biostudies-literature
2021-09-09 | PXD017089 | Pride
| S-EPMC5265847 | biostudies-other
| S-EPMC7804410 | biostudies-literature
| S-EPMC6449719 | biostudies-literature
| S-EPMC10576795 | biostudies-literature
| S-EPMC7315500 | biostudies-literature
| S-EPMC4824905 | biostudies-literature
| S-EPMC5350633 | biostudies-literature
| S-EPMC6986407 | biostudies-literature